Ekso Bionics Holdings Inc (EKSO)

[Porsche911guy]

It was so thin and 15% move with no chatter IMO is fairly bullish. The shorts let her move up and with no news they'll step back in soon. This is a my small fish or what I would call a piker trade. But it will take a lot to get through $6.

[Uranium]

Well, I was sure thinking about it...lol... Pretty small fish (position) in my pond though

[formerdtrader]

stock rips 15% and no one is talking about it?

[radly]

This is such a POS. Red and going lower every day. Way to go EKSO. You guys truly suck.

[kpisme]

Hey it went up the with R/S but only in price, not in value I guess that doesn't count. You are right this is a POS

[radly]

Good luck! This has done nothing but go down over the last 5+ years. Hope something will change

[Rhetorical]

Picked up a few more shares today, I'm tempted by an FDA announcement for EksoUE or a sales contract for Ekso EVO and would probably sell some on the news to buy back in about a week later when attention starts to fade

In any case, I think the news and new products that have come out likely have the potential to increase sales above expectations by the end of q if nothing else - hopefully back into positive EPS

[Rhetorical]

I bought some EKSO shares today, I think the Ekso EVO is gold. I made a couple smart moves recently and have extra cash for EKSO to rush in when it spikes next too.

Obviously the huge FDA ABI news is ganna create a spike that can't last as attention starts to fade, but I think their Ekso Works division actually has the better short term potential despite the most recent gains-creating headlines with Ekso NR. I'm hoping at least a little bit of that value from ABI news can translate into sales and push us into positive eps again if a Works contract doesn't come this Q.

A little abstract here, but I sort of think Ekso EVO it's like how the US will potentially largely skip 5g and go straight to 6g frequency technology in most places- out maneuvering other countries with 5g at a critical point (DARPA programs are working on THz range frequencies for god sakes and miniaturization seems to be getting better not worse). Ekso EVO has that next-level quantum leap kind of feel written all over it to me, albeit purely mechanical in nature.

I'm happy with margins and growth prospects, and the two Jack's.

Hoping EKSO can follow the trend of putting out a really good PR right before the next round of fundraising, which seems to be happening more and more frequently in my scope of observation at least, although some companies timing the top better than others.

I'm lonG EKSO

[radly]

Ekso Bionics is continuously looking for new distribution partners in countries of the EMEA region (Europe, Middle East, Africa)

Why would they not be looking for distribution partners in the US since they have none.

[Rhetorical]

New website layout: https://eksobionics.com/ekso-evo/

I'm long EKSO

[radly]

Getting about time for another split isn't it. lol

[radly]

Now if we can get a bunch of commercial/industrial contracts I might can get my investment back within the next 10 years.

[Rhetorical]

I think their Evo Suit is awesome. I'm not sure whether it will slow down or speed up their dealings with Ford, but a better product is a better product.

Looks much less bulky, more ergonomic, and more breathable with the same 15lbs per arm assistance. Really excited to see this technology keep getting better, hopefully this will kick down the door for us so to speak.

I'm long EKSO

[Rhetorical]

NEW PRODUCT: EKSO EVO --- Full Press Release:

https://www.globenewswire.com/news-release/2020/08/20/2081341/0/en/Ekso-Bionics-Unveils-its-Latest-Assistive-Exoskeleton-Innovation-for-Industrial-Use.html

[radly]

Look at this baby go. Best damn stock in the stock world for the last 5 years.

[Rhetorical]

I bought some more stock today after thinking how scared I would be to short EKSO right now. Here's why:

I think an EksoUE FDA approval might be possible. Nice that the product doesn't require power, I would imagine this would simplify things somewhat. I imagine if they can get a walking exoskeleton approved, they have a good chance here too. FDA approval headlines tend to do well for share price.

Ekso has already worked with major companies (Ford, Boeing, and licensing to Lockheed Martin) and there could be expansion with any one of those major companies. Meanwhile The Company's profit margins were 56% last quarter and they are offering new subscription/rental based sales for EksoUE at $599 per month which I think is really smart compared to a high upfront cost. This last point could compound with an FDA announcement. Of all the possibilities, I think if Ford fully integrates Ekso Vest into their production line, it might be the best possible announcement.

Looking at clinical trials, TBI/Stroke trials are active and could yield positive results. EksoNR winning Med Tech awards is a good sign.

I suppose another DARPA contract or some other DoD collaboration could be possible, especially with the CFIUS decision looming large (although TALOS cancellation should be mentioned to be fair).

Shifting macro trends: for example, exoskeletons being a central part of a Space Force episode on Netflix. I think Steve Carell is a lot more mainstream than military shooter games and sci-fi movies.

I can look at the company now compared to where they were ~5 years ago and I think that they have succeeded. Lateral growth, subscription sales, lower cost products, higher margins, FDA expansion, and their position relative to competitors-- it all seems good to me. Even their going after network healthcare provider deals, it's just in a more ambitious, but realistic place that the company is at.

As The Company gets more and more FDA approvals under their belt, I think the impetus is growing for healthcare insurance providers to start offering coverage for these devices - which would be a major positive force. One of them might do it first just to get the PR/saying that they cover robotic rehabilitation as a selling point.

I'm long EKSO

[Rhetorical]

FDA Acquired Brain Injury (ABI) approval, UE monthly rentals, and the injury reduction % numbers at Ford make me think the next year for Ekso looks good ignoring past performance. Despite share price, debt is low and products are improving

In fact, I think the path forward for Ekso has become much more clear despite the low price, and at least we're still up from where the FDA announcement was.

I'm long Ekso

[radly]

This dog still a dog. Lower and lower every day

[Rhetorical]

Ekso UE being offered at a monthly price. This is from an email I received this morning:

"Did you hear the exciting news? Our newest upper-extremity rehabilitation solution, EksoUE, is now easier to implement than ever!

For a limited time only, we are offering EksoUE by subscription for only $599 per month. This means that you will have access to the latest in upper-body rehabilitation, including all warranties, service, and upgrades. With our new online learning platform, you can learn to use EksoUE quickly, so you can get your patients into this game-changing device ASAP.

Fully mobile, naturally tracking, battery free, and compatible with activities of daily life (ADLs), EksoUE will help your patients regain their upper-body strength while they re-learn proper muscle patterns.

This device is unlike any other of its kind and, for just $599 per month, is a scalable way to help your therapists give exceptional care.

Click the button below to learn more about starting your robotics rehabilitation program with EksoUE!"

--------

I think this is a much easier entry point than starting with an EksoNR, but could easily put rehab centers along that track.

In general, I'm happy to see a subscription-based sales model

I'm long EKSO

[Majestic_Delight]

Revaluation of warrants was $8.6mm and occurred because of sp appreciation. This would have erased $1.10/sh of the total loss had it not been necessary to revalue. It was accretive when the sp was dropping. It is my hope that they have to continue to take charges for warrant revaluations.??

[Rhetorical]

Poor earnings, but not entirely unexpected I think

My longer term thoughts are that the FDA Acquired Brain Injury designation approval will reinforce Jack's efforts at getting network healthcare provider deals. Likewise on the industrial side, Ekso's tweet about their injury reduction % numbers via FORD's pilot program make me think larger scale buys might happen for Ekso Vest.

Poor numbers for the quarter mean less to me than a good overall position in the market and a growth trajectory that makes sense. Are other exoskeleton companies doing any better right now?

I'm long EKSO

[radly]

I see this company is still a POS, keep accumulating losses

[kpisme]

Going up??? must be time for another R/S

[packerfan9]

The reduction in workers compensation insurance costs alone will pay for vests and more.

[Porsche911guy]

The stock looks to be settling down both the volume and beta. This Q will be interesting to see after the raise/warrant exercise how much cash along with how well they have dealt with Covidcity. Those of you have been in long term know and have lived through the stock would've gone back to $4-5 in the old days. With the dilution and the shorts, very interesting she has held up so well. Hope they can replace the China JV or some type of solution. But 1st the Q.

We will know soon...

[Rhetorical]

Remembering to take a few deep breaths to relax is always good advice

Injury reduction doesn't directly translate into profits short term, although the path to get there is looking a lot more well lit.

Also, less than 20 people have liked the Ekso tweet releasing those numbers as of now, so I don't really think it's been seen by many.

I wish Ford retweeted the news short term, but on the other hand if they decide to expand their adoption of Ekso Vest or if it gets picked up elsewhere at scale - that'd be even better.

I'm long EKSO

[radly]

Market doesn't give a crap about this stock

[packerfan9]

The reduction in workers comp claims and insurance cost. That makes vests pay for themselves.

[1Justin44]

100 percent agree!! I put 14 percent of my retirement portfolio in this stock which is quite a bit after 21 years of building it. Highly NOT recommended by the "experts" but this is a risk worth taking. I'm 41 right now maybe retired at say 45... Sure why not. One can dream aye hahaha. Side Note: I am starting a business late this year, early next year tops (signing papers this upcoming week). It will be a owner/operator business and will require some good amount of lifting throughout the day. Something like the Exoskeleton is something I would consider purchasing in the near future. I believe they range from $4,000-$7,500 per Exoskeleton. Although that is probably a cheaper price when you buy in large quantities buy large corporations so on so forth. EKSO long and GLTA!!

[Rhetorical]

WOW, Ekso Vest: 83% injury reduction via Ford Motor Company

I think this is huge new in and of itself, granted no press-release. Thanks for sharing news of this tweet, Eksobeans!

"Since introducing #EksoVest, Ford Motor Company has observed an 83% decline in #WorkerInjuries."

The persuasion-case to buy an Ekso Vest becomes much easier with this number I'd say

This stock has been waiting quite some time for a big contract, and I'm starting to drool about it given all the recent signs that point in this direction (in my opinion).

I'm long EKSO

[Eksobeans]

It’s percolating once again... I was really encouraged by yesterday’s tweet regarding the 80% reduction in injuries at Ford. Another success story

[Eksobeans]

I must say that this has been an exciting ride of late! It took the sale of 57% of the shares that I held to eke out a nice profit (but far from spectacular). So I’m now rolling, free of charge, with the remaining 43% and will hold tight to at least above $30 a share. That share price correlates to a company market cap below $230 million, which I believe is attainable in the near term. Of course another quick pop might cause me to fold like a cheap suit... Ever since that CFIUS decision which caused the termination of the Chinese Joint Venture I’ve been daydreaming about a substantial government contract. I’m also hopeful large institutions have invested in EKSO now that we’ve remained above $5 per share. After the reverse split we’ve been left with such a small total share count, even after we recapitalized, and it was a sight to see the entire float turnover at least 10 times in one day. Who know what tomorrow will bring, I’m going to be ready with some popcorn.

[ClayTrader]

* * $EKSO Video Chart 06-29-2020 * *

Link to Video - click here to watch the technical chart video

[saigai]

looks like she wants to pivot. sellers dried up people have to unwind their short position so volume should pick up...

[JohnathanSpr]

In my opinion the company is still undervalued. Steady (but slow) revenue increase, new product and significant decrease in the expenses. Ekso NR is currently the best product on the market, the Vest is still a wild card and lets not forget about the established collaboration with hospitals, universities.
It will be interesting to see how the covid 19 situation disrupted the operations.
I think it will be still undervalued in short term but I dont expect any further share sale/offering in the next 12 months, the Q2 results will give some guidance on the cash burn.

Everyone is critizing Jack and the management, maybe rightfully, but they have a plan and they are going forward.

...my 2 cents

[Porsche911guy]

You Guys are making key points to why the company is on track, and I agree on the VA and all the possible applications and lets throw in the China JV replaced with even a better partner. Additionally the cash position could be anywhere from $15-$20 mil. won't know until the Q.

So I think numbers on the shorts could be off the charts. If 60mil. short of Thursday carried over 20mil. into Friday, maybe down to 15mil. for Monday. Who knows?

I've seen this movie in the late '90's I had a day trading outfit in the office next to mine, I would go visit and watch from time to time going from a full service quiet B/D to the day trading madness was something to watch from the sidelines and of course when they started shooting each other like Atlanta it was over. Your right this was just a stock symbol they had and still have no idea. And I do believe you could be right about above $5, I kept small 500 shares @$3.40 in each of my 3 accounts.

I just have to wait until the shorts are almost gone, algos moved on, day traders will either leave get burned or turn into long term holders I still think $25.

[Rhetorical]

Skeptic, remember the company intends it's users to recover with the EksoNR.

This company is changing the game

https://eksobionics.com/eksohealth/

I'm long EKSO

[Majestic_Delight]

Skept,

While I agree with you that most posters on ST have no clue about EKSO there is no way IMHO that as a group they could represent anything but a fraction of the 150 million shares (20+ times float) traded the last two days. Which also means to me that almost all the owners will own shares above $5/sh.

In addition, part of the excitement comes from a possible government (VA) contract which I would expect to be substantial if true. As you remember, EKSO has already qualified for a GSA with $5MM contract several months ago. What happens to the stock price if this news drops?

Lastly, whether or not it is a new product or an old product used for a new purpose really doesn’t matter and amounts to splitting hairs. The fact is that the addressable market for EKSO just got a whole lot bigger that is not currently accessible to anyone else (as far as I know)... sales or no sales.

[Rhetorical]

To me the the point is that these people you speak of are interested enough to care and to post.

I don't recall it being that way when the GT was FDA cleared

[skepticone]

I follow ST message board and it is very clear to me why this stock ran so hard on Thursday. 90% of the people on there have no freakin' clue why they were buying the stock other than the herd was buying and the price was going up. Unless more news comes out, this will drop to at least $5 and probably sub $4 in the next few months. Many believe the recent news will cause a huge revenue jump, some believe they are selling a new device to a new group of patients.

(For anyone new reading this)..While the FDA clearance will allow the current device, EKSO NR (the latest version of the previous EKSO GT) to be used for treatment of an expanded group of patients, it does not mean that every one of those patients will be buying the device. The device is not sold for personal use, it is sold or rented to rehabilitation facilities where the patients share treatment time /use with the device. Yes, some new facilities, that treat ABI (and do not treat stroke and spinal cord injuries) may now purchase or rent a device. Current customers, that currently treat stroke and spinal cord injuries could possibly expand treatment to ABI if they do that sort of treatment, may acquire an addition device or two. (not all current customers treat ABI). It will all add some revenue through support contracts for the devices. That said, the realized revenue does not warrant this huge PPS move.
Also remember that they still have authorization to issue more shares to raise more money. They have demonstrated in the past that they will use PPS increases to their benefit and issue those shares. I expect another issuance shortly. Share issuances always cause the PPS to drop.

[Porsche911guy]

I bid the board farewell for a while. I have sold most of my shares. I can't stay around when the math doesn't make any cents. I did factor in the exercise of the warrants. But 119mil then 36mil what $1.5 billion dollars trading hands. The universe is 10mil fully diluted. Additionally the day traders the algos and the shorters will be battling the longs. And what a battle it will be. This stock is more hated than the president.

To all those who buy a micro-cap with dreams of getting yourself something special with your winnings. It happens!! with my winnings I'm upgrading to the Porsche GT-3RS.I'll order next year never know could be bo-go by then. Best of luck, I'll be back for the run to $25

[Rhetorical]

I'd say we still have a ways to until recovery for most shareholders, but it might not necessarily be such a long ways.

I think the FDA news opens up so much potential in terms of creating a network healthcare deal, catalyzing future business prospects.

The extra market value will make future fundraising so much better too.

I'm calling this one a loonshot and I predict it'll be a $100+ tenbagger in less than 5 years.

What passes for a unicorn in silicon valley today is absolutely pathetic. It boggles my mind how much more potential Ekso has compared to a lot of apps/software, while simultaneously having positive earnings per share (at least for one quarter).

Picking Ekso as a growth stock for me feels a lot more safe than buying into a company losing billions per year.

Don't call it a penny stock now.

I'm long EKSO

[Rhetorical]

https://www.benzinga.com/news/20/06/16411313/why-ekso-bionics-stock-is-trading-higher-today

[radly]

So the only person you to blame for not buying more to lower your cost basis is yourself. Even so, if your truly LONG - you may still well come out ahead in the future.

Some are of us are not made of money. Will hold this for another 10 years and a few more splits and see where it is by then.

[ClayTrader]

* * $EKSO Video Chart 06-26-2020 * *

Link to Video - click here to watch the technical chart video

[saigai]

1.5 billion in money flow so far 2 days..maybe we can grab 200 million in mkt cap out of that..

[saigai]

holding 300% in a down mkt with friday go cash day..so far!.

[Rhetorical]

This is better: https://money.cnn.com/quote/forecast/forecast.html?symb=ekso#:~:text=Stock%20Price%20Forecast,the%20last%20price%20of%208.00.

[Rhetorical]

Found it: https://www.nasdaq.com/market-activity/stocks/ekso/analyst-research

[Rhetorical]

Got a link?